Key details
Sponsor
Lo.Li.Pharma s.r.l
Enrollment target
~100 participants
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
25 Years – 65 Years
Last updated November 2025